32 years of investing in a complicated jigsaw...

Equity analyst Laura Nelson Carney uses her PhD in neuroscience to help spot medical innovation around the world. She brings a deep understanding of science to health care investing, using her research and drug development experience to help identify breakthrough drugs. And today ...  Show more

Brittain Ezzes, a portfolio manager for Capital Group Dividend Value ETF, shares her perspective on an unexpected rally this year among heavy-asset companies, or companies outside of AI and big tech. She offers three catalysts that could sustain the rally, identifies areas where ...  Show more

Regional sovereign funds backed local economies amid pandemic while investors have also shifted their strategies to focus more on equity markets and ESG opportunities. This is according to the latest report from US asset management firm Invesco, which surveyed 141 chief investmen ...  Show more

Jorge Quintanilla Nielsen started the private asset management firm Capital SAFI in 2007 — and planned to expand from Bolivia across South America. As a private firm, Capital SAFI isn’t required to have a board, but he knew that governance would be one of the main aspects potenti ...  Show more

On today’s show we are talking about deal structure. Some of the financing vehicles that are increasingly common in real estate had their roots on Wall Street. Others had their roots in the tech environment of Silicon Valley. 

When investors want to participate in a sta ...

On today’s show we are talking about how to determine the structure of an investment offering. 

We often hear about the so-called 2 & 20 formula that is popular among fund managers. When we say 2 & 20, that refers to a 2% asset management fee measured on the val ...